🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to learn whether a higher dose of cetiri...
Status
Recruiting
Location
University of Phayao Hospital
Start Date
2025-11-15
Trial ID
NCT07236372
Treatments Being Tested
The study is a Phase II, dose-ranging, multicenter, randomized, double-blin...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00866788
Treatments Being Tested
Patients with HBeAG positive, chronic HBV infection will receive either ARC...
Status
Terminated
Location
Research Site 1
Start Date
2015-11
Trial ID
NCT02604212
Treatments Being Tested
This is a randomized, multicenter, phase II clinical trial evaluating proph...
Status
Recruiting
Location
Yale University
Start Date
2026-08-15
Trial ID
NCT07426822
Treatments Being Tested
This was a randomized, double-blind, parallel-group, multicenter study that...
Status
Terminated
Location
Multiple Locations
Start Date
2004-03-01
Trial ID
NCT00751166
Treatments Being Tested
This study will assess the ability of montelukast to improve the signs and ...
Status
Completed
Location
Multiple Locations
Start Date
2001-11
Trial ID
NCT00974571
Treatments Being Tested
Patients with chronic HBV infection will receive either ARC-520 or placebo ...
Status
Terminated
Location
Research Site 1
Start Date
2015-09
Trial ID
NCT02604199
Treatments Being Tested
The objective of the study is to evaluate the efficacy and tolerability of ...
Status
Completed
Location
Multiple Locations
Start Date
2005-05
Trial ID
NCT00504933
Treatments Being Tested
This phase IV investigational trial is being conducted to evaluate the effi...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-08-01
Trial ID
NCT01916226
Treatments Being Tested
Patients with chronic HBV infection will receive either ARC-520 alone or AR...
Status
Terminated
Location
Research Site 3
Start Date
2015-12
Trial ID
NCT02577029
Treatments Being Tested